Loading article...
US company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai HQed company pips the consortium of EQT-Gruenthal. Sun will pay $4.5 billion for Organon’s equity and inherit $8.5 billio…
Mumbai: Indias most valuable drug maker Sun Pharmaceutical Industries is set to make its biggest and most ambitious overseas acquisition till date, a near $12.5 billion acquisition of New Jersey-base… [+5949 chars]
Continue reading on The Times of India
Read Full Article